Abstract
Purpose
The purpose of this study was evaluation of the efficacy of the first step of a two-stage procedure for treatment of hip prosthetic joint infection (PJI) using articulating and non-articulating spacers as well as development of a prediction model and prognostic score for infection recurrence.
Methods
In a cohort of 217 patients treated for PJI of the hip, demographic characteristics, clinical symptoms, body temperature, body mass index (BMI), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), white blood cell count (WBC), microbiological cultures and the type of the spacer used were retrospectively analyzed for association with the recurrence of PJI.
Results
Patients with infection recurrence had increased levels of ESR and CRP (P < 0.001) together with higher BMI and shorter infection manifestation period after previous surgery (P < 0.05). Among these patients, there was no significant difference of clinical characteristics between subjects with articulating and non-articulating spacers. Microbial associations were more often identified in patients with recurrent infection (50 %, P < 0.01) where Gram-negative bacteria were predominant (61.5 %, P < 0.01). These patients had higher percentage of Acinetobacter sp. and P. aeruginosa isolates (28.2 %, P < 0.01).
Conclusions
Efficacy of the first step of two-stage revision was 64.1 %. Placement of either articulating or non-articulating spacers did not influence recovery from PJI. Laboratory values of ESR, CRP, BMI and the type of previous surgery were identified as main factors that affect outcomes of the two-stage procedure. A prognostic model with the calculation of a total risk score for PJI recurrence was developed.
Similar content being viewed by others
References
Lichstein P, Gehrke T, Lombardi A, Romano C, Stockley I, Babis G, Bialecki J, Bucsi L, Cai X, Cao L, de Beaubien B, Erhardt J, Goodman S, Jiranek W, Keogh P, Lewallen D, Manner P, Marczynski W, Mason JB, Mulhall K, Paprosky W, Patel P, Piccaluga F, Polkowski G, Suarez J, Thorey F, Tikhilov R, Velazquez JD, Winkler H (2014) One-stage vs two-stage exchange. J Arthroplast 29:108. doi:10.1016/j.arth.2013.09.048
Katz JN, Losina E, Barrett J, Phillips CB (2001) Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States Medicare population. J Bone Joint Surg 83:1622–1629
Pulido L, Ghanem E, Joshi A, Purtill JJ (2008) Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 466:1710. doi:10.1007/s11999-008-0209-4
Puhto AP, Puhto T, Syrjala H (2012) Short-course antibiotics for prosthetic joint infections treated with prosthesis retention. Clin Microbiol Infect 18:1143. doi:10.1111/j.1469-0691.2011.03693.x
Phillips JE, Crane TP, Noy M, Elliott TSJ, Grimer RJ (2006) The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br Vol 88-B:943. doi:10.1302/0301-620x.88b7.17150
Bongartz T, Halligan CS, Osmon DR, Reinalda MS, Bamlet WR, Crowson CS, Hanssen AD, Matteson EL (2008) Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum 59:1713. doi:10.1002/art.24060
Schmalzried TP (2006) The infected hip: telltale signs and treatment options. J Arthroplast 21:97. doi:10.1016/j.arth.2006.02.090
Anagnostakos K (2009) Classification of hip joint infections. Int J Med Sci 6:227–233. doi:10.7150/ijms.6.227
Berend KR, Lombardi AV, Morris MJ, Bergeson AG, Adams JB, Sneller MA (2012) Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res 471:510. doi:10.1007/s11999-012-2595-x
Bejon P, Berendt A, Atkins BL, Green N, Parry H, Masters S, Mclardy-Smith P, Gundle R, Byren I (2010) Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology. J Antimicrob Chemother 65:569. doi:10.1093/jac/dkp469
Kilgus DJ, Howe DJ, Strang A (2002) Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop Relat Res 404:116. doi:10.1097/00003086-200211000-00021
Betsch BY, Eggli S, Siebenrock KA, Täuber MG, Mühlemann K (2008) Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis 46:1221. doi:10.1086/529436
Hanssen AD, Osmon DR (2002) Evaluation of a staging system for infected hip arthroplasty. Clin Orthop Relat Res 403:16. doi:10.1097/00003086-200210000-00004
Giulieri SG, Graber P, Ochsner PE, Zimmerli W (2004) Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 32:222–228. doi:10.1007/s15010-004-4020-1
Berbari EF, Osmon DR, Duffy MCT, Harmssen RNW, Mandrekar JN, Hanssen AD, Steckelberg JM (2006) Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 42:216. doi:10.1086/498507
Marculescu CE, Cantey JR (2008) Polymicrobial prosthetic joint infections: risk factors and outcome. Clin Orthop Relat Res 466:1397. doi:10.1007/s11999-008-0230-7
Volin SJ, Hinrichs SH, Garvin KL (2004) Two-stage reimplantation of total joint infections: a comparison of resistant and non-resistant organisms. Clin Orthop Relat Res 427:94–100. doi:10.1097/01.blo.0000143559.34143.3d
Widmer AF (2001) New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 33:S94. doi:10.1086/321863
Salgado CD, Dash S, Cantey JR, Marculescu CE (2007) Higher risk of failure of methicillin-resistant staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res 461:48–53. doi:10.1097/blo.0b013e3181123d4e
Ghanem E, Antoci V, Pulido L, Joshi A, Hozack W, Parvizi J (2009) The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis 13:e444. doi:10.1016/j.ijid.2009.02.017
Hsieh P, Lee MS, Hsu K, Chang Y, Shih H, Ueng SW (2009) Gram-negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis 49:1036. doi:10.1086/605593
Zmistowski B, Fedorka CJ, Sheehan E, Deirmengian G, Austin MS, Parvizi J (2011) Prosthetic joint infection caused by gram-negative organisms. J Arthroplast 26:104. doi:10.1016/j.arth.2011.03.044
Sabry FY, Buller L, Ahmed S, Klika AK, Barsoum WK (2014) Preoperative prediction of failure following two-stage revision for knee prosthetic joint infections. J Arthroplast 29:115. doi:10.1016/j.arth.2013.04.016
Ilchmann T, Zimmerli W, Ochsner PE, Kessler B, Zwicky L, Graber P, Clauss M (2015) One-stage revision of infected hip arthroplasty: outcome of 39 consecutive hips. Int Orthop. doi:10.1007/s00264-015-2833-4
Triantafyllopoulos GK, Poultsides LA, Sakellariou VI, Zhang W, Sculco PK, Ma Y, Sculco TP (2015) Irrigation and debridement for periprosthetic infections of the hip and factors determining outcome. Int Orthop 39:1203. doi:10.1007/s00264-015-2753-3
Vielgut I, Sadoghi P, Wolf M, Holzer L, Leithner A, Schwantzer G, Poolman R, Frankl B, Glehr M (2015) Two-stage revision of prosthetic hip joint infections using antibiotic-loaded cement spacers: When is the best time to perform the second stage? Int Orthop 39(9):1731–1736. doi:10.1007/s00264-015-2751-5
Wimmer MD, Friedrich MJ, Randau TM, Ploeger MM, Schmolders J, Strauss AA, Hischebeth GTR, Pennekamp PH, Vavken P, Gravius S (2015) Polymicrobial infections reduce the cure rate in prosthetic joint infections: outcome analysis with two-stage exchange and follow-up ≥two years. Int Orthop. doi:10.1007/s00264-015-2871-y
Acknowledgments
This study was supported by the grant №115030510010 from the Ministry of Health of the Russian Federation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Tikhilov, R., Bozhkova, S., Denisov, A. et al. Risk factors and a prognostic model of hip periprosthetic infection recurrence after surgical treatment using articulating and non-articulating spacers. International Orthopaedics (SICOT) 40, 1381–1387 (2016). https://doi.org/10.1007/s00264-015-3072-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-015-3072-4